2016
DOI: 10.18632/aging.100898 View full text |Buy / Rent full text
|
|

Abstract: The role of p53 family member, p63 in oncogenesis is the subject of controversy. Limited research has been done on the clinical implications of p63 expression in diffuse large B-cell lymphoma (DLBCL). In this study, we assessed p63 expression in de novo DLBCL samples (n=795) by immunohistochemistry with a pan-p63-monoclonal antibody and correlated it with other clinicopathologic factors and clinical outcomes. p63 expression was observed in 42.5% of DLBCL, did not correlate with p53 levels, but correlated with … Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
14
0

Publication Types

Select...

Relationship

0
0

Authors

Journals